Itragrap TF 100mg/250mg Tablet
By Itragrap TF
Rx
10 Tablet in a Strip

Composition
Itraconazole(100mg) + Terbinafine(250mg)

Manufacturer - Grapple Life Sciences Pvt Ltd
Grapple Life Sciences Private Limited, SCF 1025, 1st & 2nd Floor, Motor Market, Manimajra, Chandigarh – 160101, India

Expires on or after
July, 2025

liver
When taking Itragrap TF 100mg/250mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. It is advised to consult with your doctor before starting treatment. This tablet is not recommended for individuals with severe or active liver disease. If you experience any signs or symptoms of jaundice while on Itragrap TF 100mg/250mg Tablet, be sure to inform your doctor promptly.

kidney
Itragrap TF 100mg/250mg Tablet should be used carefully in patients with kidney disease. Adjusting the dosage may be necessary. Consult your doctor.

alcohol
Caution is advised when consuming alcohol with Itragrap TF 100mg/250mg Tablet. It is recommended to consult your doctor regarding alcohol intake.

driving
When taking Itragrap TF 100mg/250mg Tablet, be cautious while driving as it may cause side effects that can impact your driving ability.

pregnancy
Itragrap TF 100mg/250mg Tablet may not be safe to use during pregnancy. Limited human studies suggest potential harm to the developing baby based on animal studies. Your doctor will assess benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Itragrap TF 100mg/250mg Tablet may not be safe during breastfeeding. Limited data indicates it could pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹280
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025